9.56
Vertex Pharmaceuticals Incorporated
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
13.2
FY23:
14.1
FY24:
9.60
FY25:
11.2
(positive)
Change from FY21 to FY25
billions USD
FY21:
3.87
FY22:
4.92
FY23:
8.59
FY24:
12.9
FY25:
14.4
Total assets
Change from FY21 to FY25
billions USD
FY21:
13.4
FY22:
18.2
FY23:
22.7
FY24:
22.5
FY25:
25.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
2.14
FY22:
2.74
FY23:
3.55
FY24:
3.56
FY25:
3.86
(negative)
Change from FY21 to FY25
billions USD
FY21:
1.19
FY22:
1.50
FY23:
1.60
FY24:
2.56
FY25:
3.12
(positive)
Change from FY21 to FY25
billions USD
FY21:
10.1
FY22:
13.9
FY23:
17.6
FY24:
16.4
FY25:
18.7
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
13.4
FY22:
18.2
FY23:
22.7
FY24:
22.5
FY25:
25.6
All amounts in billions USD